Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD. Methods: ApoE genotypes, systemic (C-reactive protein [CRP], fibrinogen, serum amyloid-A [SAA]) and vascular inflammatory markers (Lipoprotein-associated phospholipase A 2 [Lp-PLA 2] and pentraxin-3 [PTX-3]) were assessed in 324 Caucasians and 208 African Americans, undergoing coronary angiography. Results: For both ethnic groups, Lp-PLA 2 index, an integrated measure of Lp-PLA 2 mass and activity, increased significantly and stepwise across apoE isoforms (P = 0.009 and P = 0.026 for African Americans and Caucasians respectively). No differences were found for other inflammatory markers tested (CRP, fibrinogen, SAA and PTX-3). For the top cardiovascular score tertile, apo E4 carriers had a significantly higher level of Lp-PLA 2 index in both ethnic groups (P = 0.027 and P = 0.010, respectively). Conclusion: The presence of the apo E4 isoform was associated with a higher level of Lp-PLA 2 index, a marker of vascular inflammation. Our results suggest that genetic variation at the apoE locus may impact cardiovascular disease risk through enhanced vascular inflammation.

Original languageEnglish (US)
Pages (from-to)230-234
Number of pages5
JournalAtherosclerosis
Volume223
Issue number1
DOIs
StatePublished - Jul 2012

Fingerprint

1-Alkyl-2-acetylglycerophosphocholine Esterase
Apolipoprotein E4
Apolipoproteins E
Blood Vessels
Serum Amyloid A Protein
Coronary Artery Disease
Ethnic Groups
African Americans
C-Reactive Protein
Fibrinogen
Protein Isoforms
Inflammation
Coronary Angiography
Cardiovascular Diseases
Genotype

Keywords

  • ApoE genotype
  • Coronary artery disease
  • Ethnicity
  • Inflammation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. / Gungor, Zeynep; Erdembileg, Anuurad; Byambaa, Enkhmaa; Zhang, Wei; Kim, Kyoungmi; Berglund, Lars.

In: Atherosclerosis, Vol. 223, No. 1, 07.2012, p. 230-234.

Research output: Contribution to journalArticle

@article{138fe7cb89de44eaa63f248ab8b407b5,
title = "Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk",
abstract = "Objective: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD. Methods: ApoE genotypes, systemic (C-reactive protein [CRP], fibrinogen, serum amyloid-A [SAA]) and vascular inflammatory markers (Lipoprotein-associated phospholipase A 2 [Lp-PLA 2] and pentraxin-3 [PTX-3]) were assessed in 324 Caucasians and 208 African Americans, undergoing coronary angiography. Results: For both ethnic groups, Lp-PLA 2 index, an integrated measure of Lp-PLA 2 mass and activity, increased significantly and stepwise across apoE isoforms (P = 0.009 and P = 0.026 for African Americans and Caucasians respectively). No differences were found for other inflammatory markers tested (CRP, fibrinogen, SAA and PTX-3). For the top cardiovascular score tertile, apo E4 carriers had a significantly higher level of Lp-PLA 2 index in both ethnic groups (P = 0.027 and P = 0.010, respectively). Conclusion: The presence of the apo E4 isoform was associated with a higher level of Lp-PLA 2 index, a marker of vascular inflammation. Our results suggest that genetic variation at the apoE locus may impact cardiovascular disease risk through enhanced vascular inflammation.",
keywords = "ApoE genotype, Coronary artery disease, Ethnicity, Inflammation",
author = "Zeynep Gungor and Anuurad Erdembileg and Enkhmaa Byambaa and Wei Zhang and Kyoungmi Kim and Lars Berglund",
year = "2012",
month = "7",
doi = "10.1016/j.atherosclerosis.2012.04.021",
language = "English (US)",
volume = "223",
pages = "230--234",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk

AU - Gungor, Zeynep

AU - Erdembileg, Anuurad

AU - Byambaa, Enkhmaa

AU - Zhang, Wei

AU - Kim, Kyoungmi

AU - Berglund, Lars

PY - 2012/7

Y1 - 2012/7

N2 - Objective: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD. Methods: ApoE genotypes, systemic (C-reactive protein [CRP], fibrinogen, serum amyloid-A [SAA]) and vascular inflammatory markers (Lipoprotein-associated phospholipase A 2 [Lp-PLA 2] and pentraxin-3 [PTX-3]) were assessed in 324 Caucasians and 208 African Americans, undergoing coronary angiography. Results: For both ethnic groups, Lp-PLA 2 index, an integrated measure of Lp-PLA 2 mass and activity, increased significantly and stepwise across apoE isoforms (P = 0.009 and P = 0.026 for African Americans and Caucasians respectively). No differences were found for other inflammatory markers tested (CRP, fibrinogen, SAA and PTX-3). For the top cardiovascular score tertile, apo E4 carriers had a significantly higher level of Lp-PLA 2 index in both ethnic groups (P = 0.027 and P = 0.010, respectively). Conclusion: The presence of the apo E4 isoform was associated with a higher level of Lp-PLA 2 index, a marker of vascular inflammation. Our results suggest that genetic variation at the apoE locus may impact cardiovascular disease risk through enhanced vascular inflammation.

AB - Objective: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD. Methods: ApoE genotypes, systemic (C-reactive protein [CRP], fibrinogen, serum amyloid-A [SAA]) and vascular inflammatory markers (Lipoprotein-associated phospholipase A 2 [Lp-PLA 2] and pentraxin-3 [PTX-3]) were assessed in 324 Caucasians and 208 African Americans, undergoing coronary angiography. Results: For both ethnic groups, Lp-PLA 2 index, an integrated measure of Lp-PLA 2 mass and activity, increased significantly and stepwise across apoE isoforms (P = 0.009 and P = 0.026 for African Americans and Caucasians respectively). No differences were found for other inflammatory markers tested (CRP, fibrinogen, SAA and PTX-3). For the top cardiovascular score tertile, apo E4 carriers had a significantly higher level of Lp-PLA 2 index in both ethnic groups (P = 0.027 and P = 0.010, respectively). Conclusion: The presence of the apo E4 isoform was associated with a higher level of Lp-PLA 2 index, a marker of vascular inflammation. Our results suggest that genetic variation at the apoE locus may impact cardiovascular disease risk through enhanced vascular inflammation.

KW - ApoE genotype

KW - Coronary artery disease

KW - Ethnicity

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84863105080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863105080&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2012.04.021

DO - 10.1016/j.atherosclerosis.2012.04.021

M3 - Article

VL - 223

SP - 230

EP - 234

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -